How a Multiple Sclerosis Medication Works in Real-World Patient Care

This is a real-world study tracking how well ofatumumab works in people with relapsing multiple sclerosis when prescribed through regular medical care in Greece. Researchers will collect health information from patients who have recently started this medication, following them for two years to see how effective the treatment is and how it impacts their daily lives.

While this medication has been tested in controlled research settings, this study wants to understand how well it truly works when patients use it in everyday doctor's offices and clinics—not just in research hospitals. This helps doctors know what to expect when recommending this treatment to newly diagnosed patients.